Differential Predictors and Clinical Implications Associated With Long-Term Survivors in IDH Wildtype and Mutant Glioblastoma.

Front Oncol · 2021 · PMC8155513 · PMID 34055603

Europe PMC DOI

hedged sentence

0.1550

closest p · 3.1× alpha

0.1550

boldest claim

The sentences

showed a trendP =0.155not close (p > 0.1)

LTS with mutant IDH showed a trend towards increased survival after receiving re-operation ( P =0.155) and reirradiation ( P =0.127), while this clinical benefit disappeared in the subset of LTS with wildtype IDH ( P >0.05).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.